Vertex Pharmaceuticals Incorporated to acquire Alpine Immune Sciences, Inc. for $4.9 billion in cash
Acquiring Company
Vertex Pharmaceuticals
Acquired Company
Alpine Immune Sciences
BostonSeattleBiotechnologyHealth CareTherapeuticsBiotechnologyDescription
Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share in cash, totaling approximately $4.9 billion. This strategic acquisition aims to leverage the scientific innovation of Alpine to create transformative medicines targeting serious diseases with high unmet need in specialty markets.
Quick answer
Vertex Pharmaceuticals is acquiring Alpine Immune Sciences for $4.9 billion, announced April 10, 2024. Vertex Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did Vertex Pharmaceuticals pay for Alpine Immune Sciences?
- The reported deal value is $4.9 billion.
- What does Vertex Pharmaceuticals do?
- Vertex is a global biotechnology company focused on innovative medicines for serious diseases.
- Where are Vertex Pharmaceuticals and Alpine Immune Sciences based?
- Vertex Pharmaceuticals is based in Boston, Massachusetts, United States. Alpine Immune Sciences is based in Seattle, Washington, United States.
- Who are the decision-makers at Vertex Pharmaceuticals?
- Fundz holds 3 contacts at Vertex Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Vertex Pharmaceuticals, and when
When Vertex Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Vertex Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vertex Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vertex Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vertex Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Alpine Immune Sciences?
Alpine Immune Sciences was acquired by Vertex Pharmaceuticals, based in Boston. The deal was reported on April 10, 2024. Vertex is a global biotechnology company focused on innovative medicines for serious diseases. Vertex Pharmaceuticals is publicly traded (VRTX) and operates in Biotechnology.
When did Vertex Pharmaceuticals acquire Alpine Immune Sciences?
Vertex Pharmaceuticals's acquisition of Alpine Immune Sciences was reported on April 10, 2024. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share in cash, totaling approximately $4.9 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Alpine Immune Sciences do?
Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat autoimmune and inflammatory diseases. It is privately held, operating in Biotechnology, and is based in Seattle.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.